1. Home
  2. PLBY vs QSI Comparison

PLBY vs QSI Comparison

Compare PLBY & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLBY

PLBY Group Inc.

HOLD

Current Price

$1.35

Market Cap

204.4M

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.85

Market Cap

191.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBY
QSI
Founded
1953
2013
Country
United States
United States
Employees
N/A
145
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.4M
191.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PLBY
QSI
Price
$1.35
$0.85
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.00
$1.00
AVG Volume (30 Days)
654.9K
6.1M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
N/A
EPS
N/A
N/A
Revenue
$120,928,000.00
N/A
Revenue This Year
$9.17
N/A
Revenue Next Year
$7.10
$618.07
P/E Ratio
N/A
N/A
Revenue Growth
4.13
N/A
52 Week Low
$1.19
$0.69
52 Week High
$2.75
$3.10

Technical Indicators

Market Signals
Indicator
PLBY
QSI
Relative Strength Index (RSI) 46.71 37.39
Support Level $1.23 $0.69
Resistance Level $1.48 $1.08
Average True Range (ATR) 0.08 0.08
MACD 0.01 -0.03
Stochastic Oscillator 33.85 15.57

Price Performance

Historical Comparison
PLBY
QSI

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: